4//SEC Filing
Hagerty David T 4
Accession 0001209191-12-034773
CIK 0001103390other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 6:49 PM ET
Size
11.9 KB
Accession
0001209191-12-034773
Insider Transaction Report
Form 4
Hagerty David T
Senior VP & CMO
Transactions
- Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$6.00/sh−134,616$807,696→ 0 totalExercise: $26.00Exp: 2021-02-28→ Common Stock (134,616 underlying) - Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2012-06-19$13.06/sh−33,600$438,816→ 0 totalExercise: $18.94Exp: 2021-12-15→ Common Stock (33,600 underlying) - Disposition to Issuer
Common Stock
2012-06-19$32.00/sh−140$4,480→ 0 total - Disposition to Issuer
Incentive Stock Option (right to buy)
2012-06-19$6.00/sh−15,384$92,304→ 0 totalExercise: $26.00Exp: 2021-02-28→ Common Stock (15,384 underlying)
Footnotes (2)
- [F1]Includes 140 shares acquired under the Ardea Biosciences, Inc. ("Ardea") 2000 Employee Stock Purchase Plan on June 12, 2012.
- [F2]This option was canceled pursuant to the Agreement and Plan of Merger, dated as of April 21, 2012, by and among Ardea, Zeneca Inc. and QAM Corp. (the "Merger Agreement"), in exchange for a payment in cash, without interest and less the amount of any required tax withholding, equal to the product of: (i) the excess of $32.00 (the per share merger consideration pursuant to the Merger Agreement) over the exercise price of the option; and (ii) the number of shares of Ardea common stock underlying the option.
Documents
Issuer
Ardea Biosciences, Inc./DE
CIK 0001103390
Entity typeother
Related Parties
1- filerCIK 0001513859
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 6:49 PM ET
- Size
- 11.9 KB